These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21295623)

  • 21. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
    Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
    Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
    Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential profiling of human red blood cells during storage for 52 selected microRNAs.
    Kannan M; Atreya C
    Transfusion; 2010 Jul; 50(7):1581-8. PubMed ID: 20158686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentially expressed microRNAs in small cell lung cancer.
    Miko E; Czimmerer Z; Csánky E; Boros G; Buslig J; Dezso B; Scholtz B
    Exp Lung Res; 2009 Oct; 35(8):646-64. PubMed ID: 19895320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.
    Wu F; Zikusoka M; Trindade A; Dassopoulos T; Harris ML; Bayless TM; Brant SR; Chakravarti S; Kwon JH
    Gastroenterology; 2008 Nov; 135(5):1624-1635.e24. PubMed ID: 18835392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of islet-specific microRNAs during human pancreatic development.
    Joglekar MV; Joglekar VM; Hardikar AA
    Gene Expr Patterns; 2009 Feb; 9(2):109-13. PubMed ID: 18977315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression analysis of suppression of tumorigenicity 13 gene in patients with Parkinson's disease.
    Shadrina MI; Filatova EV; Karabanov AV; Slominsky PA; Illarioshkin SN; Ivanova-Smolenskaya IA; Limborska SA
    Neurosci Lett; 2010 Apr; 473(3):257-9. PubMed ID: 20193743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of microRNAs regulated by activin A in human embryonic stem cells.
    Tsai ZY; Singh S; Yu SL; Kao LP; Chen BZ; Ho BC; Yang PC; Li SS
    J Cell Biochem; 2010 Jan; 109(1):93-102. PubMed ID: 19885849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients.
    Voellenkle C; van Rooij J; Cappuzzello C; Greco S; Arcelli D; Di Vito L; Melillo G; Rigolini R; Costa E; Crea F; Capogrossi MC; Napolitano M; Martelli F
    Physiol Genomics; 2010 Aug; 42(3):420-6. PubMed ID: 20484156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
    Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNAs involved in Parkinson's disease: A systematic review.
    da Silva FC; Iop RD; Vietta GG; Kair DA; Gutierres Filho PJ; de Alvarenga JG; da Silva R
    Mol Med Rep; 2016 Nov; 14(5):4015-4022. PubMed ID: 27666518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.
    Leite KR; Sousa-Canavez JM; Reis ST; Tomiyama AH; Camara-Lopes LH; Sañudo A; Antunes AA; Srougi M
    Urol Oncol; 2011; 29(3):265-9. PubMed ID: 19372056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression changes in blood as a putative biomarker for Huntington's disease.
    Lovrecic L; Kastrin A; Kobal J; Pirtosek Z; Krainc D; Peterlin B
    Mov Disord; 2009 Nov; 24(15):2277-81. PubMed ID: 19844910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
    Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
    Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation analysis of microRNA-7 gene in Chinese patients with Parkinson's disease.
    Zhang X; Guo J; Ai S; Hu Y; Sun Q; Xu Q; Lu Z; Li K; Dong X; Shen L; Jiang H; Pan Q; Xia K; Yan X; Tang B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1189-92. PubMed ID: 23281385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of microRNAs for the early diagnosis of Parkinson's disease and multiple system atrophy.
    Yan JH; Hua P; Chen Y; Li LT; Yu CY; Yan L; Zhang H; He Y; Zheng H; Chen H; Zhang ZJ; Yao QH; Dong H; Liu WG
    J Integr Neurosci; 2020 Sep; 19(3):429-436. PubMed ID: 33070521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy.
    Todorović Z; Dzoljić E; Novaković I; Mirković D; Stojanović R; Nesić Z; Krajinović M; Prostran M; Kostić V
    J Neurol Sci; 2006 Oct; 248(1-2):56-61. PubMed ID: 16774768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signatures of microRNAs and selected microRNA target genes in human melanoma.
    Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
    Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
    Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
    Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.